Accenture · 13 hours ago
Business Analyst - Disease Surveillance Conversion BA Tester ^6149288
Accenture is a leading global professional services company recognized for its commitment to diversity and innovation. The Business Analyst - Disease Surveillance Conversion BA Tester will support data conversion activities for a public health system implementation, ensuring data quality and collaborating with various teams to facilitate successful project outcomes.
ConstructionEnterprise SoftwareConsultingOutsourcingInformation TechnologyBusiness Information SystemsInformation ServicesInfrastructureManagement Consulting
Responsibilities
Support data conversion activities for a public health system implementation, including requirements analysis, data mapping, validation, and conversion related testing
Analyze legacy and target systems to document conversion requirements and mapping rules
Validate data transformations and support data quality checks and reconciliation. Develop and execute conversion test scenarios and test cases (mock loads, SIT/UAT support)
Track and resolve defects related to conversion and data accuracy
Collaborate with functional, technical, and client teams to confirm readiness for mock conversions, dress rehearsals, and go‑live
Ensure converted data meets public health program standards and supports end‑to‑end business processes
Qualification
Required
Minimum 4 years of work experience
Minimum of 2 years of data conversion experience on large system implementations
HS Diploma / GED
Preferred
Background as a Business Analyst and/or Tester (public sector or public health preferred)
Strong skills in data mapping, validation, reconciliation, and defect management
Proficiency with Excel and basic SQL for data review
Experience using test management and tracking tools (e.g., Azure DevOps, Jira)
Benefits
Medical
Dental
Vision
Long-term disability coverage
401(k) plan
Paid time off
Company
Accenture
Accenture is a professional services company that provides solutions in strategy, consulting, digital, technology and operations.
Funding
Current Stage
Public CompanyTotal Funding
$6MKey Investors
Youth Business International
2018-10-01Grant· $6M
2001-07-27IPO
Leadership Team
Recent News
legacy.thefly.com
2026-02-12
Company data provided by crunchbase